News

May 9, 2025
It was a true honor for Arterna Biosiences to take part in the state visit to Sweden by the President of Iceland, held from May 6th to 8th 2025 , as one of the participating Icelandic biotech companies.
​
April 10, 2025
Arterna Biosciences participated at the Summit of Cancer Immunotherapy, organized and hosted by BioCanRx Canada. We are truly inspired by the great work done by BioCanRx in Canada.
​
March 26, 2025
We are proud to launch our latest product- the ZebraScribe SP6 Transcription Kit ! Specifically designed for Zebrafish research. This kit enables high-yield production of ARCA-capped mRNA through in vitro transcription, powered by our ultrapure SP6 RNA polymerase.
​
January 13, 2025
We are happy to share that Klara Sveinsdóttir has joined our team as Chief of Operations. Klara has a masters degree in pharmacy from the University of Iceland and MBA degree from the University of Reykjavík. Welcome Klara !
​
​
January 9, 2025​
We are happy to share that Stefán Eggertsson has joined our team as a Research Scientist. Stefán has a Masters degree in Molecular Biology from the University of Iceland. Welcome Stefán !
​
October 29, 2024
Today we signed a collaboration agreement with the BioMedical Center, University of Iceland, as we scale up our production and development program. We continue our mission to improve the quality of mRNA for better therapeutics.
​​
​
December 1, 2023
Arterna was awarded a grant from the Innovator Grant Fund (Frumkvöðlasjóður) from Íslandsbanki. This is a competitive grant program that aims to support local businesses that also honor UN guidelines of technical innovation and equality.
​
​
August 28, 2023
We are happy to share that Clara Valls Ferre has joined the Arterna team as a research specialist. Welcome Clara!
​
​
June 8, 2023
Today, the Icelandic Technology Development Fund announced that Arterna will receive a Growth grant for expanding the development program and for marketing purposes.
​
​
July 22, 2022
Valerie Helene Maier has joined the board, bringing valuable expertise to the development of Arterna RNA biology platforms and business strategy.
​
Jan 24, 2022
We are happy to share that Laura Lorenzo-Soler has joined the Arterna team as a research specialist. Welcome Laura!
Dec 9, 2021
Today, the Icelandic Technology Development Fund announced that Arterna has been awarded a grant to further its development program in order to generate better RNA enzymes.